Lupin, Dr Reddy's Labs: 5 pharma stocks CLSA revises stance on
As benchmark indices edge higher after beginning the session flat, CLSA has revised its stance on five pharmaceutical stocks. The list includes names such as Dr. Reddy's Laboratories, Lupin, Gland Pharma, and others. Here is a revised list of pharma stocks by the brokerage.
(DISCLAIMER: The views and investment tips expressed by investment experts on zeebiz.com are their own and not those of the website or its management. zeebiz.com advises users to check with certified experts before taking any investment decisions.)
Dr Reddy's Laboratories
Dr Reddy's Laboratories:
CLSA upgraded Dr Reddy's Laboratories to 'hold' and gave the target of Rs 6,080.
Sun Pharma
Sun Pharma:
It upgraded Sun Pharma stock to 'underperform' and gave the target of Rs 756.
Ipca Laboratories
Ipca Laboratories:
The brokerage upgraded Ipca Laboratories stock to 'underperform' and gave a target of Rs 900 apiece.
Lupin
Lupin:
CLSA upgraded Lupin to 'underperform' and gave a target of Rs 1,420.
Gland Pharma
Gland Pharma:
By downgrading the rating to 'outperform' for Gland Pharma the brokerage gave a target of Rs 3,120.